A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design

Trials including diabetic subjects without cardiovascular disease or proteinuria generate few events and require substantial participant numbers to achieve adequate power. However, the presence of coexisting cardiovascular disease or proteinuria increases event rates multiple-fold. Such data should aid investigators designing diabetes end-point trials.